Rondrique, Zhayesha S.

HRN: 21-47-12  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/14/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/14/2023
11/20/2023
IV
250mg
Q8h
Amoebiasis
Waiting Final Action 
11/14/2023
AMPICILLIN 500MG (VIAL)
11/14/2023
11/20/2023
IV
500mg
Q6h
PCAP B
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: